Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Diastolic Dysfunction in Peritoneal Dialysis
NCT01503671Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Nov 2011
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of atorvastatin in heart failure with preserved ejection fraction (HFpEF) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Left ventricular diastolic function at 1 year. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT01503671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01503671.